INTROOUCTION We have previously reported t h a t s a l i v a and plasma of patients with c y s t i c f i b r o s i s (CF) i s deficient i n the enzyme a c t i v i t y hydrolyzing esters o f arginine (12.14). and docmented the p r o t e o l y t i c nature of the a c t i v i t y (14). Recently, we have reported t h a t t h i s reduction i n protease a c t i v i t y
can be demonstrated usina 4-meth~lumbellifer~lc~uanidinobenzoate (MUGB), an active s i t e t i t r a n t o f t;ypsin-l;ke proteas& i n chloroform-ellagic acid activated plas~na o f patients w i t h c y s t i c f i b r o s i s (11, 15) .
There was a concomitant decrease i n p r o t e o l y t i c a c t i v i t y towards esters of ar i n l n e i n these actlvated Plasma samPles. as has Dreviouslv been described 714). It was also reported t h a t unactihted-plasma s'amples reacted w i t h MUGB t o the same extent (nmoles 4-methylumbelliferone released per rnl plasma) as d i d the activated sam~les w i t h s i a n i f l c a n t differences i n the t i t r e values maintained between contr'ol, obligate-heterozygotes, and patients with CF. These unactivated plasma samples had negligible c a t a l y t i c a c t i v i t y towards the classical ester substrates derived from L-arginine. U n t i l recently, i t had not been possible t o demonstrate a s i m i l a r reduct i o n i n protease a c t i v i t y i n cultivated skin fibroblasts derived fran patients w i t h c y s t i c f i b r o s i s using conventional substrates,probably due t o the ins e n s i t i v i t y o f the procedures. We now present data on the determination o f protease a c t i v i t y i n cultivated human skin fibroblasts using MUGB and the demonstration of a reduction i n t h i s a c t i v i t y i n fibroblasts derived frm patients w i t h c y s t i c fibrosis. Furthermore, we also present data on the quantitation of t h i s a c t i v i t y i n c u l t i v a t e d hman amniotic f l u i d cells.
MATERIALS AND METHODS

Chemicals
Benzamidine'HCl and 4-methylumbelliferylguanidinobenzoate (MUGB) were purchased f r a n Sigma Chemical Company (16). Dimethylsulfoxide used as the solvent for MUGB was obtained f r a n J.T. Baker Chemical Company (17). (pitropheny1)-pguanidinobenzoate (NPGB) was purchased f r a n N u t r i t i o n a l Blochemical Corporation (18). e-hydroxymecuribenzoate (HMB) was from Schwartzl Mann (19).
Source o f Human 'Skin Fibroblasts and Amniotic F l u i d Cells
Human skin fibroblasts were obtained e i t h e r from stock cultures i n our laboratory o r frm the Human Genetic Mutant Repository (20). Skin biopsies from patients w i t h CF, obligate heterozygotes,and control subjects were obtained w i t h informed consent under the guidelines of the Department o f Health, Education, and Welfare and w i t h the approval o f the Human Ethics and Research Comnittee of the Children's Memorial Hospital. Human amniotic f l u i d c e l l s obtained a t approximately sixteen weeks o f pregnancy were from routine amniocentesis.
Cell Cultures
Human fibroblasts were grown from skin biopsies and amniotic f l u i d c e l l s were cultivated by standard methods as previously described (10) . Experiment a l use o f skin fibroblast l i n e s was discontinued a f t e r 20 passages. For the growth experiments, minimal essential medium containing 15% f e t a l c a l f s e r m w i t h p e n i c i l l i n , streptomycin, and fungizone added was changed on the t h i r d and seventh day a f t e r i n i t i a l planting. The fibroblasts were harvested i n saline by scraping and the homogenates prepared as described below.
Preparation o f Cell Hanogenates
Human skin fibroblasts and amniotic f l u i d c e l l s were harvested by scraping the flasks w i t h a rubber policeman. Cells being prepared f o r assay w i t h MUGB were not harvested w i t h trypsin,which has been shown t o react w i t h MUGB (7). The c e l l s were xashed with 0.85% saline and spun i n a c l i n i c a l centrifuge f o r 15 minutes a t 4 C. This procedure was repeated three times. The washed c e l l s were resuspended i n 0.01 M Verona1 HC1-saline solution. pH 8.3.
Usually, c e l l s from s i x flasks were resuspended i n 0.4-0.6 ml of the veronal-saline solution for sonication. The c e l l s were homogenized f o r one minute. The microtip o f the sonifier (Heat Systems Ultrasonics. Inc., Model W 185 (21) ) was set t o maximlim and the suspension sonicated i n i c e i n bursts o f ten seconds. The hanogenate was spun a t 600 x g i n a c l i n i c a l centrifuge for 15 minutes a t 40C and the low speed supernatant used i n the assay system. The low speed supernatant was used e i t h e r imnediately o r stored a t -10%.
Storage f o r up t o t h i r t y days d i d not affect the assay. The washed p e l l e t obtained from the centrifugation was found t o react with MUGB; however, most o f the 4-methylumb e l l i f e r o n e (4-MU) released (85-90%) was due t o non-specific hydrolysis of the substrate.
Assay Methods
The reaction o f low speed supernatants obtained from cultivated skin fibroblast and amniotic f l u i d c e l l hanogenates was performed as previously described for plasma (11.15) (22) ) with excit a t i o n a t 365 nm and emission a t 450 nm. Appropriate blanks were run i n p a r a l l e l t o correct f o r the spontaneous l i b e r a t i o n o f 4-MU. Each time point was r o u t i n e l y done i n t r i p l i c a t e . Protease a c t i v i t y was taken as the d i fference between the amount o f 4-MU liberated i n the presence and absence o f 0.2 M benzamidine, documented t o i n h i b i t plasma proteases known t o be d e f i c i e n t i n c y s t i c f i b r o s i s (11.15).
The 4-MU reaction values obtained i n the presence o f benzamidine were presumably due t o the non-specific hydrolysis o f the substrate. The 4-NU liberated i n the presence and absence of benzamidine i s also corrected f o r the spontaneous hydrolysis of MUGB by substituting buffer for the supernatant i n the reaction mixture. Since the amino acid side chains present i n tissue proteins hydrolyze MUGB nonspecifically t o a greater extent than when they are coagulated by boiling, use of benzamidine i n presence of soluble protein i s a b e t t e r approach than using boiled blanks t o determine the contribution due t o p r o t e o l y t i c a c t i v i t y . (Fig. 1) .
Effect of Culture Conditions on MUGB Reactivity
The (Fig. 2b) Figure 3 . Significant differences were observed i n the extent o f reaction of the supernatant proteases w i t h MUG6 between the controls (N), obligate heterozygotes (H) and c y s t i c fibrosis (CF) samples. The mean " t i t r e " values (nmoles 4-MU released per mg protein) which are corrected f o r non-specific hydrolysis using benzamidine fran 8 N was 1.27 i 0.11; 8H, 0.82 t 0.12 and 14 patients w i t h CF. 0.66 i 0.10. The " t i t r e " values f o r N:CF and N:H were s i g n i f i c a n t l y d i f f e r e n t with a p o f less than 0.001 and f o r CF:H, 0.01.
The mean t o t a l 4-MU liberated by the supernatant proteases of CF l i n e s i s approximately 50% t h a t of controls. T i t r a t i o n experiments using low speed supernatants obtained f r a n c u l t i v a t e d human anniotic f l u i d c e l l hanogenates have s h w t h a t the reaction i s I n h i b i t e d by benzamidine and the mean " t i t r e "
value i s 1.29 i 0.17 nmoles 4-MU released per mg protein (Fig. 3) .
Mixing equal volumes of f i b r o b l a s t supernatant samples from controls and patients yielded the expected intermediate values f o r the 4-MU liberated.
OISCUSSION
These data indicate a s i g n i f i c a n t reduction i n the number o f protease molecules which react with the t i t r a n t . MUGB, when the low speed supernatants fran cultivated s k i n f i b r o b l a s t hanogenates dervied f r a n patients w i t h cystic f i b r o s i s are canpared t o controls (Fig. 3) . Mixing experiments ruled out the presence of any i n h i b i t o r i n samples f r a n fibroblasts dervied from patients w i t h cystic fibrosis. This i s not surprising, since even strong i n h
i b i t o r s l i k e soybean t r y p s i n i n h i b i t o r had no e f f e c t on the reaction o f MUGB w i t h plasma proteases, due t o the high a f f i n i t y o f MUGB t o the active s i t e s of the enzymes. Previous work fran t h i s laboratory demonstrated a deficiency of protease a c t i v i t y i n plasma and s a l i v a o f patients w i t h c y s t i c fibrosis by
measurin the rate of hydrolysis of esters of L-arginine (13.14) and protamine (143. Recently, we demonstrated a reduction i n the amount o f MUGB-react i v e proteases i n both chloroform-ellagic acid activated and unactivated plasma f r a n Patients w i t h c v s t i c fibrosis (11.15) .
MUG6 has been em~loyed as an act i v e k i t e t i t r a n t in-both pure (7.8) and crude (2) systems. I t Hlso was found t o be a very sensitive indicator of STI-inhibited protease molecules i n elasma (11.15).
I n plasma, i t was suggested t h a t the differences i n the mean t i t r e " values (nmoles 4-MU released per ml plasma) between c y s t i c f i b r o s i s and control plasmas represented a reduced number of protease molecules I n c y s t i c fibrosis rather than a decrease i n t h e i r c a t a l y t i c efficiency. Similar observations are apparent i n the MUGB " t i t r a t t o n " assays w i t h c u l t i v a t e d human skin f i b r o b l a s t proteases.
Reaction characteristics s i m i l a r t o those reported for plasma (11.15 ) are observed when the low speed supernatants prepared from c u l t i v a t e d human skin fibroblast hanogenates were reacted with MUGB. The reaction i s essentially canplete i n 60 minutes (Fig. 1) s i m i l a r t o t h a t reported for both plasma (11, 15) and thranbin (7) but much slower than t h a t reported for t r y p s i n and Factor X (7). It i s proportional t o protein concentration, independent o f MUGB concentration and i n h i b i t e d by both NPGB, an active s i t e t i t r a n t o f tryps i n and the nitrophenyl analog o f MUGB (4.5) and benzamidine, a highly specific, competitive i n h i b i t o r o f t r y p s i n -l i k e proteases (5). Though nonspecific hydrolysis i s Indicated by the formation o f 4-MU I n the presence of both benzamidine (Fig. 1) and NPGB, the amount of non-specific hydrolysis was found t o be the same f o r both the control and c y s t i c f i b r o s i s c e l l l i n e (Fig.  1) . The reaction of MUGB w i t h f i b r o b l a s t supernatants probably involves a mixture of proteases. The release o f 4-MU may be due t o " t i t r a t i o n " o f some of these proteases and the turnover of MUGB as a substrate by others. Although the conbributlon of each o f these components cannot be c l e a r l y ident i f i e d a t present, the strong a f f i n i t y of MUGB f o r the active s i t e o f many proteases (2, 7, 8) and the s e n s i t i v i t y of fluorometry makes t h i s approach extremely adaptable t o small amounts of t r y p s i n -l i k e proteases known t o be irwortant i n c y s t i c fibrosis (11) (12) (13) (14) (15) ).
It i s also possible t h a t the f i b r o b l a s t proteases are i n an inactive, precursor f o n , i n which case synthetic substrates would not be effective; but MUGB, which I s known t o react w i t h trypsinogen (8) and protease precursors I n plasma (11.15) might react with both precursors and active forms of proteases i n ftbroblasts.
The nature of the p r o t e o l y t i c a c t i v i t y which i s present i n cultivated human s k i n fibroblasts and " t i t r a t e d " with MUGB i s not known. However, i t i s not the plasminogen activator, a serine protease (6) . because the MUGBreactive species i s neither soluble nor i s i t i n our experiments e a s i l y solubilized. HMB, an i n h i b i t o r of t h i o l proteases (1) has no effect on the liberat i o n of 4-MU i n t h i s assay system s i m i l a r t o results reported f o r plasma (14) .
indicating i t i s not t h i o l protease such as cathepsin B (1)
optimum different fran those pmteases known t o be deficient i n patients w i t h CF (11) (12) (13) (14) (15) .
The react i o n of fibroblast proteases i s i n h i b i t e d both by benzamidine (Fig. 1) and NPGB indicating the involvement o f t r y p s i n -l i k e molecules and i t i s thought t h a t the WGB-reactive enzymes are probably neutral proteases associated w i t h the plasma membranes. The exact nature of t h i s a c t i v i t y remains t o be defined.
The techniques o f quantitation o f f i b r o b l a s t proteases w i t h MUGB has been demonstrated t o be both very sensitive and reproducible, and can detect very low levels of proteases h i t h e r t o very d i f f i c u l t t o demonstrate using standard r a t e assays. The reduced levels of proteases i n saliva (12) . plasma (11. 13-15) , and cultivated human skin c e l l fibroblasts derived from patients with cystic f i b r o s i s suggests t h a t t h i s reduction i n a c t i v i t y i s a generalized phenomenon i n c y s t i c fibrosis. Refinement o f these techniques may permit heterozygote and intrauterine detection.
CONCLUSION
A reduction i n c e l l u l a r proteases assayed using MUGB has been demonstrated i n the la, speed supernatants prepared from c u l t i v a t e d skin fibroblast hanogenates derived from patients with CF. Significant differences are observed i n the extent o f reaction o f f i b r o b l a s t proteases w i t h MUGB when comearisons are made between control and c y s t i c fibrosis c e l l lines. The mean t i t r e " value (nmoles 4-MU released per mg protein) obtained f o r the f i b r ob l a s t l i n e s derived fran patients with CF i s approximately 50% of t h a t of the normal lines. MUGB r e a c t t v t t y has also been documented i n cultivated control amniotic f l u i d cells. These data are consistent w i t h our e a r l i e r suggestion t h a t decreased p r o t e o l y t i c a c t i v i t y i n the plasma o f patients with c y s t i c fibrosis may be the r e s u l t of fewer protease molecules rather than differences i n t h e i r c a t a l y t i c e f f i c i e n c y (11.15) .
This apparent reduction i n protease levels would seem t o be a generalized phenomenon i n the tissues and f l u i d s of patients w i t h c y s t i c fibrosis. 
